Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood

Transfusion

Volumn 52, Issue 2, 2012, Pages 409-416

  Tonnetti, Laura ^a,b   Thorp, Aaron M ^a,b   Reddy, Heather L ^a,b   Keil, Shawn D ^a,b   Goodrich, Raymond P ^a,b   Leiby, David A ^a,b  

^a HOLLAND LABORATORY   (United States)

^b CaridianBCT Biotechnologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOFLAVIN;

ARTICLE; BLOOD; BLOOD CULTURE; BLOOD TRANSFUSION; CHAGAS DISEASE; DISEASE TRANSMISSION; HUMAN; ILLUMINATION; MEDICAL INSTRUMENTATION; NONHUMAN; PARASITE IDENTIFICATION; PHOTOCHEMISTRY; TRYPANOSOMA CRUZI; ULTRAVIOLET RADIATION;

3T3 CELLS; ALGORITHMS; ANIMALS; BLOOD DONORS; BLOOD-BORNE PATHOGENS; CELLS, CULTURED; CHAGAS DISEASE; DISINFECTANTS; HUMANS; MICE; MICROBIAL VIABILITY; PARASITE LOAD; RIBOFLAVIN; STERILIZATION; TRYPANOSOMA CRUZI; ULTRAVIOLET RAYS;

EID: 84855854717     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03285.x     Document Type: Article

References (31)

1. Organizaciõn Panamericana de la Salud. Estimaciõn cuantitativa de la enfermedad de Chagas en las Americas. Document OPS/HDM/CD/425-06. Montevideo, Uruguay: Organizaciõn Panamericana de la Salud; 2006.
2. Schmunis GA,. The globalization of Chagas disease. ISBT Sci Ser 2007; 2: 6-11.
3. Weinman D, MacAlister J,. Prolonged storage of human phatogenic protozoa with conservation of virulence. Am J Hyg 1947; 45: 102-21.
4. Filardi LS, Brener Z,. Cryopreservation of Trypanosoma cruzi bloodstream forms. J Protozool 1975; 22: 398-401.
5. Nickerson P, Orr P, Schroeder ML, Sekla L, Johnson JB,. Transfusion-associated Trypanosoma cruzi infection in a non-endemic area. Ann Intern Med 1989; 111: 851-3. (Pubitemid 19283923)
6. Grant IH, Gold JW, Wittner M, Tanowitz HB, Nathan C, Mayer K, Reich L, Wollner N, Steinhertz L, Ghavimi F, O'Reilly RJ, Armstrong D,. Transfusion-associated acute Chagas disease acquired in the United States. Ann Intern Med 1989; 111: 849-51. (Pubitemid 19283922)
7. Cimo PL, Luper EL, Scouros MA,. Transfusion-associated Chagas' disease in Texas: report of a case. J Texas Med 1993; 89: 48-50.
8. Leiby DA, Lenes BA, Tibbals MA, Tames-Olmedo MT,. Prospect evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med 1999; 341: 1237-9. (Pubitemid 29480668)
9. Young C, Losikoff P, Chawla A, Glasser L, Forman E,. Transfusion-aquired Trypanosoma cruzi infection. Transfusion 2007; 47: 540-4.
10. Centers for Disease Control and Prevention. Chagas disease after organ transplantation-United States, 2001. MMWR Morb Mortal Wkly Rep 2002; 51: 210-2.
11. Centers for Disease Control and Prevention. Chagas disease after organ transplantation-United States, 2006. MMWR Morb Mortal Wkly Rep 2006; 55: 798-800.
12. Kun H, Moore A, Mascola L, Steurer F, Lawrence G, Kubak B, Radhakrishna S, Leiby D, Herron R, Mone T, Hunter R, Kuehnert M,; Chagas Disease in Transplant Recipients Investigation Team. Transmission of Trypanosoma cruzi by heart transplantation. CID 2009; 48: 1534-40.
13. Cardo LJ, Salata J, Mendez J, Reddi H, Goodrich R,. Pathogen inactivation of Trypanosoma cruzi in plasma and platelets concentrates using riboflavin and ultraviolet light. Transfus Apher Sci 2007; 37: 131-37. (Pubitemid 350181574)
14. Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP,. Photochemical inactivation of selected viruses and bacteria in platelets concentrated using riboflavin and light. Transfusion 2004; 44: 877-85. (Pubitemid 38738418)
15. Fast LD, Dileone G, Li J, Goodrich R,. Functional inactivation of white blood cells by Mirasol treatment. Transfusion 2006; 46: 642-8.
16. Fast LD, Dileone G, Cardarelli G, Li J, Goodrich R,. Mirasol PRT treatment of donor white blood cells prevents the development of xenogenic grft-versus-host disease in Rag2-/-gamma C-/- double knockout mice. Transfusion 2006; 46: 1553-60. (Pubitemid 44326331)
17. Asano H, Lee CY, Fox-Talbot K, Koh CM, Erdinc MM, Marschner K, Keil S, Goodrich R, Baldwin WM 3rd,. Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusion and cardiac transplant. Transplantation 2007; 84: 1174-82. (Pubitemid 350125361)
18. Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J, Goodrich RP,. Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood inactivation. Transfus Med Rev 2008; 22: 133-53. (Pubitemid 351384824)
19. Tonnetti L, Proctor MC, Reddy HL, Goodrich RP, Leiby DA,. Evaluation of the Mirasol pathogen reduction technology system against Babesia microti in apheresis platelets and plasma. Transfusion 2009; 50: 1010-27.
20. ICH Q5A(R1)-viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. September 23, 1999.
21. Cancelas JA, Dumont LJ, Rugg N, Szczepiorkowski ZM, Herschel L, Siegel A, Pratt PG, Worsham DN, Erickson A, Propst M, North A, Sherman CD, Mufti NA, Reed WF, Corash L,. Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process. Transfusion 2011 (epub ahead of print).
22. Goodrich RP, Doane S, Reddy HL,. Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products. Biologicals 2010; 38: 20-30.
23. Duffy T, Bisio M, Altcheh J, Burgos JM, Diez M, Levin MJ, Favaloro RR, Freilij H, Schijman AG,. Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in Chagas disease patients. PLoS Negl Trop Dis 2009; 3: e419.
24. Woody NC, Woody HB,. American trypanosomiasis (Chagas' disease); first indigenous case in the United States. JAMA 1955; 159: 676-7.
25. Ochs DE, Hnilica VS, Moser DR, Smith JH, Kirchhoff LV,. Postmortem diagnosis of autochthonous acute chagasic myocarditis by polymerase chain reaction amplification of a species-specific DNA sequence of Trypanosoma cruzi. Am J Trop Med Hyg 1996; 54: 526-9. (Pubitemid 26162249)
26. Herwaldt BL, Grijalva MJ, Newsome AL, McGhee CR, Powell MR, Nemec DG, Steurer FJ, Eberhard ML,. Use of polymerase chain reaction to fiagnose the fifth reported US case of autochthonous transmission of Trypanosoma cruzi in Tennessee,1998. J Infect Dis 2000; 181: 395-9. (Pubitemid 30049078)
27. Schiffler RJ, Mansur GP, Navin TR, Limpakarnjanarat K,. Indigenous Chagas' disease (American trypanosomiasis) in California. JAMA 1984; 251: 2983-4. (Pubitemid 14119865)
28. Dorn PL, Perniciaro L, Yabsley MJ, Roelling DM, Balsamo G, Diaz J, Wesson D,. Autochthonous transmission of Trypanosoma cruzi, Luisiana. Emerg Infect Dis 2007; 13: 605-7. (Pubitemid 46525117)
29. Agapova M, Busch MP, Custer B,. Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi. Transfusion 2010; 50: 2220-32.
30. CDC. Blood donor screening for Chagas disease-United States, 2006-2007. MMWR Morb Mortal Wkly Rep 2007; 56: 141-3.
31. Castro E,. Chagas's disease: lesson from routine donation testing. Transfus Med 2009; 19: 16-23.